世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2309
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、第IX因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・第IX因子欠乏症治療の市場動向
・企業の競争状況、市場シェア
・第IX因子欠乏症治療の種類別市場規模（血友病B、血友病B阻害剤）
・第IX因子欠乏症治療の用途別市場規模（病院、クリニック、その他）
・第IX因子欠乏症治療の北米市場規模2016-2027（アメリカ、カナダ）
・第IX因子欠乏症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・第IX因子欠乏症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・第IX因子欠乏症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・第IX因子欠乏症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Takeda、Novo Nordisk、Biogen、CSL Behring）
・結論

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.
In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market during the forecast period. Factors such a low cost and high efficiency are the key contributors to the dominance of this segment in the global market.

Market Analysis and Insights: Global Factor IX Deficiency Treatment Market
The global Factor IX Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Factor IX Deficiency Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Factor IX Deficiency Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Factor IX Deficiency Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Factor IX Deficiency Treatment market.

Global Factor IX Deficiency Treatment Scope and Market Size
Factor IX Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Factor IX Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hemophilia B
Hemophilia B Inhibitors

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Takeda
Novo Nordisk
Biogen
CSL Behring

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Factor IX Deficiency Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hemophilia B
1.2.3 Hemophilia B Inhibitors
1.3 Market by Application
1.3.1 Global Factor IX Deficiency Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Factor IX Deficiency Treatment Market Perspective (2016-2027)
2.2 Factor IX Deficiency Treatment Growth Trends by Regions
2.2.1 Factor IX Deficiency Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Factor IX Deficiency Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Factor IX Deficiency Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Factor IX Deficiency Treatment Industry Dynamic
2.3.1 Factor IX Deficiency Treatment Market Trends
2.3.2 Factor IX Deficiency Treatment Market Drivers
2.3.3 Factor IX Deficiency Treatment Market Challenges
2.3.4 Factor IX Deficiency Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Factor IX Deficiency Treatment Players by Revenue
3.1.1 Global Top Factor IX Deficiency Treatment Players by Revenue (2016-2021)
3.1.2 Global Factor IX Deficiency Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Factor IX Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Factor IX Deficiency Treatment Revenue
3.4 Global Factor IX Deficiency Treatment Market Concentration Ratio
3.4.1 Global Factor IX Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Factor IX Deficiency Treatment Revenue in 2020
3.5 Factor IX Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Factor IX Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Factor IX Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Factor IX Deficiency Treatment Breakdown Data by Type
4.1 Global Factor IX Deficiency Treatment Historic Market Size by Type (2016-2021)
4.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Type (2022-2027)

5 Factor IX Deficiency Treatment Breakdown Data by Application
5.1 Global Factor IX Deficiency Treatment Historic Market Size by Application (2016-2021)
5.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Factor IX Deficiency Treatment Market Size (2016-2027)
6.2 North America Factor IX Deficiency Treatment Market Size by Type
6.2.1 North America Factor IX Deficiency Treatment Market Size by Type (2016-2021)
6.2.2 North America Factor IX Deficiency Treatment Market Size by Type (2022-2027)
6.2.3 North America Factor IX Deficiency Treatment Market Size by Type (2016-2027)
6.3 North America Factor IX Deficiency Treatment Market Size by Application
6.3.1 North America Factor IX Deficiency Treatment Market Size by Application (2016-2021)
6.3.2 North America Factor IX Deficiency Treatment Market Size by Application (2022-2027)
6.3.3 North America Factor IX Deficiency Treatment Market Size by Application (2016-2027)
6.4 North America Factor IX Deficiency Treatment Market Size by Country
6.4.1 North America Factor IX Deficiency Treatment Market Size by Country (2016-2021)
6.4.2 North America Factor IX Deficiency Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Factor IX Deficiency Treatment Market Size (2016-2027)
7.2 Europe Factor IX Deficiency Treatment Market Size by Type
7.2.1 Europe Factor IX Deficiency Treatment Market Size by Type (2016-2021)
7.2.2 Europe Factor IX Deficiency Treatment Market Size by Type (2022-2027)
7.2.3 Europe Factor IX Deficiency Treatment Market Size by Type (2016-2027)
7.3 Europe Factor IX Deficiency Treatment Market Size by Application
7.3.1 Europe Factor IX Deficiency Treatment Market Size by Application (2016-2021)
7.3.2 Europe Factor IX Deficiency Treatment Market Size by Application (2022-2027)
7.3.3 Europe Factor IX Deficiency Treatment Market Size by Application (2016-2027)
7.4 Europe Factor IX Deficiency Treatment Market Size by Country
7.4.1 Europe Factor IX Deficiency Treatment Market Size by Country (2016-2021)
7.4.2 Europe Factor IX Deficiency Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Factor IX Deficiency Treatment Market Size (2016-2027)
8.2 Asia-Pacific Factor IX Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Factor IX Deficiency Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Factor IX Deficiency Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Factor IX Deficiency Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Factor IX Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Factor IX Deficiency Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Factor IX Deficiency Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Factor IX Deficiency Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Factor IX Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Factor IX Deficiency Treatment Market Size (2016-2027)
9.2 Latin America Factor IX Deficiency Treatment Market Size by Type
9.2.1 Latin America Factor IX Deficiency Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Factor IX Deficiency Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Factor IX Deficiency Treatment Market Size by Type (2016-2027)
9.3 Latin America Factor IX Deficiency Treatment Market Size by Application
9.3.1 Latin America Factor IX Deficiency Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Factor IX Deficiency Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Factor IX Deficiency Treatment Market Size by Application (2016-2027)
9.4 Latin America Factor IX Deficiency Treatment Market Size by Country
9.4.1 Latin America Factor IX Deficiency Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Factor IX Deficiency Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Factor IX Deficiency Treatment Market Size (2016-2027)
10.2 Middle East & Africa Factor IX Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Factor IX Deficiency Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Factor IX Deficiency Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Factor IX Deficiency Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Factor IX Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Factor IX Deficiency Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Factor IX Deficiency Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Factor IX Deficiency Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Factor IX Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Factor IX Deficiency Treatment Introduction
11.1.4 Pfizer Revenue in Factor IX Deficiency Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Factor IX Deficiency Treatment Introduction
11.2.4 Takeda Revenue in Factor IX Deficiency Treatment Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Factor IX Deficiency Treatment Introduction
11.3.4 Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Factor IX Deficiency Treatment Introduction
11.4.4 Biogen Revenue in Factor IX Deficiency Treatment Business (2016-2021)
11.4.5 Biogen Recent Development
11.5 CSL Behring
11.5.1 CSL Behring Company Details
11.5.2 CSL Behring Business Overview
11.5.3 CSL Behring Factor IX Deficiency Treatment Introduction
11.5.4 CSL Behring Revenue in Factor IX Deficiency Treatment Business (2016-2021)
11.5.5 CSL Behring Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Factor IX Deficiency Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hemophilia B
Table 3. Key Players of Hemophilia B Inhibitors
Table 4. Global Factor IX Deficiency Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Factor IX Deficiency Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Factor IX Deficiency Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Factor IX Deficiency Treatment Market Share by Regions (2016-2021)
Table 8. Global Factor IX Deficiency Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Factor IX Deficiency Treatment Market Share by Regions (2022-2027)
Table 10. Factor IX Deficiency Treatment Market Trends
Table 11. Factor IX Deficiency Treatment Market Drivers
Table 12. Factor IX Deficiency Treatment Market Challenges
Table 13. Factor IX Deficiency Treatment Market Restraints
Table 14. Global Factor IX Deficiency Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Factor IX Deficiency Treatment Market Share by Players (2016-2021)
Table 16. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor IX Deficiency Treatment as of 2020)
Table 17. Ranking of Global Top Factor IX Deficiency Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Factor IX Deficiency Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Factor IX Deficiency Treatment Product Solution and Service
Table 21. Date of Enter into Factor IX Deficiency Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Factor IX Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Factor IX Deficiency Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Factor IX Deficiency Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Factor IX Deficiency Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Factor IX Deficiency Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Factor IX Deficiency Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Factor IX Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Factor IX Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Factor IX Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Factor IX Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Factor IX Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Factor IX Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Factor IX Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Factor IX Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Factor IX Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Factor IX Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Factor IX Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Factor IX Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Factor IX Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Factor IX Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Factor IX Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Factor IX Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Factor IX Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Factor IX Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Factor IX Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Factor IX Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Factor IX Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Factor IX Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Factor IX Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Factor IX Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Factor IX Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Factor IX Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Factor IX Deficiency Treatment Product
Table 64. Pfizer Revenue in Factor IX Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Takeda Company Details
Table 67. Takeda Business Overview
Table 68. Takeda Factor IX Deficiency Treatment Product
Table 69. Takeda Revenue in Factor IX Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 70. Takeda Recent Development
Table 71. Novo Nordisk Company Details
Table 72. Novo Nordisk Business Overview
Table 73. Novo Nordisk Factor IX Deficiency Treatment Product
Table 74. Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 75. Novo Nordisk Recent Development
Table 76. Biogen Company Details
Table 77. Biogen Business Overview
Table 78. Biogen Factor IX Deficiency Treatment Product
Table 79. Biogen Revenue in Factor IX Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 80. Biogen Recent Development
Table 81. CSL Behring Company Details
Table 82. CSL Behring Business Overview
Table 83. CSL Behring Factor IX Deficiency Treatment Product
Table 84. CSL Behring Revenue in Factor IX Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 85. CSL Behring Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Factor IX Deficiency Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hemophilia B Features
Figure 3. Hemophilia B Inhibitors Features
Figure 4. Global Factor IX Deficiency Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Factor IX Deficiency Treatment Report Years Considered
Figure 9. Global Factor IX Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Factor IX Deficiency Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Factor IX Deficiency Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Factor IX Deficiency Treatment Market Share by Regions (2022-2027)
Figure 13. Global Factor IX Deficiency Treatment Market Share by Players in 2020
Figure 14. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor IX Deficiency Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Factor IX Deficiency Treatment Revenue in 2020
Figure 16. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Factor IX Deficiency Treatment Market Share by Type (2016-2027)
Figure 20. North America Factor IX Deficiency Treatment Market Share by Application (2016-2027)
Figure 21. North America Factor IX Deficiency Treatment Market Share by Country (2016-2027)
Figure 22. United States Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Factor IX Deficiency Treatment Market Share by Type (2016-2027)
Figure 26. Europe Factor IX Deficiency Treatment Market Share by Application (2016-2027)
Figure 27. Europe Factor IX Deficiency Treatment Market Share by Country (2016-2027)
Figure 28. Germany Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Factor IX Deficiency Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Factor IX Deficiency Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Factor IX Deficiency Treatment Market Share by Region (2016-2027)
Figure 38. China Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Factor IX Deficiency Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Factor IX Deficiency Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Factor IX Deficiency Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Factor IX Deficiency Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Factor IX Deficiency Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Factor IX Deficiency Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Factor IX Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Factor IX Deficiency Treatment Business (2016-2021)
Figure 58. Takeda Revenue Growth Rate in Factor IX Deficiency Treatment Business (2016-2021)
Figure 59. Novo Nordisk Revenue Growth Rate in Factor IX Deficiency Treatment Business (2016-2021)
Figure 60. Biogen Revenue Growth Rate in Factor IX Deficiency Treatment Business (2016-2021)
Figure 61. CSL Behring Revenue Growth Rate in Factor IX Deficiency Treatment Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor VIII Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2310 2021年4月 128Pages
QYResearch社発行の本調査資料では、第VIII因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北...

世界の第IX因子欠乏症治療市場 2021：企業別、地域別、種類・用途別

Global Factor IX Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z05432 2021年4月 100Pages
当調査資料では、第IX因子欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。第IX因子欠乏症治療の種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の第VIII因子欠乏症治療市場 2021：企業別、地域別、種類・用途別

Global Factor VIII Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z05433 2021年4月 123Pages
当調査資料では、第VIII因子欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。第VIII因子欠乏症治療の種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米...

世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Vitamin D Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5957 2021年4月 92Pages
QYResearch社発行の本調査資料では、ビタミンD欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンD2、ビタミンD3）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Growth Hormone Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2639 2021年4月 90Pages
QYResearch社発行の本調査資料では、成長ホルモン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術）、用途別市場規模（病院、診療所、在宅ケア）、主要地域別市場規模（北米、ア...

世界のチロシンヒドロキシラーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Tyrosine Hydroxylase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5773 2021年4月 91Pages
QYResearch社発行の本調査資料では、チロシンヒドロキシラーゼ欠損症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（投薬、言語療法、その他）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

Global CARD9 Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1109 2021年4月 96Pages
QYResearch社発行の本調査資料では、CARD9欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（全身性抗真菌性感染症、表面的抗真菌性感染症）、用途別市場規模（病院、クリニック、薬局、その他）、主要地域別市場規模（北米、アメリカ、...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

世界のアルファ-アンチトリプシン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0255 2021年4月 133Pages
QYResearch社発行の本調査資料では、アルファ-アンチトリプシン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CT-2009、POL-6014、ARO-AAT、ALNAAT-02、その他）、用途別市場規模（クリニック、病院、そ...

世界の第IX因子欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Factor IX Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
世界の第VIII因子欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Factor VIII Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
世界の血友病A・B組換え因子補充療法市場規模・現状・予測（2021年-2027年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Treatment Market The global Adenosine Deaminase Deficiency Treat…